TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
11.10
0.05 (0.45%)
At close: Aug 15, 2025, 10:07 AM
0.45% (1D)
| Bid | 7.92 |
| Market Cap | 9.25M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.51M |
| EPS (ttm) | -792.4 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -1.15 |
| Analyst | Buy |
| Ask | 14.33 |
| Volume | 3,681 |
| Avg. Volume (20D) | 114,432 |
| Open | 11.70 |
| Previous Close | 11.05 |
| Day's Range | 11.10 - 11.70 |
| 52-Week Range | 6.15 - 739.20 |
| Beta | 1.48 |
About RNAZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RNAZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RNAZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-21.22%
TransCode Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
3 months ago
-9.18%
TransCode Therapeutics shares are trading lower after the company announced a 1-for-28 reverse stock split
